NSRX Nasus Pharma Ltd.
Company Analysis
Latest News
🟢 Nasus Pharma is trading 10.14% up today after FDA clearance for NS002 IND
Nasus Pharma is trading at $3.75, up +10.14% on September 14, 2026, after the FDA cleared its IND application for NS002, an investigational intranasal...
Nasus Pharma Gets the FDA Green Light for a Needle-Free EpiPen Rival — But Can a $62 Million Company Crack a Multibillion-Dollar Market?
Shares of Nasus Pharma jumped 8.4% to $3.69 Monday morning after the company announced the FDA cleared its application to begin a pivotal clinical trial of an...
🟢 Nasus Pharma is trading 8.1% up today after FDA clearance of NS002 IND
Nasus Pharma is trading 8.1% up at $3.68 after the FDA cleared its IND application for NS002, an investigational intranasal epinephrine powder for...
🟢 Nasus Pharma is trading 8.4% up today after FDA clearance for its NS002 IND application
Nasus Pharma is trading 8.4% higher at $3.69 after the U.S. FDA cleared its Investigational New Drug (IND) application for NS002, an intranasal epinephrine...
🔴 Nasus Pharma is trading 7% down today after hotter-than-expected August PPI
Nasus Pharma is trading at $3.30, down -7.04%, as broader risk-off sentiment intensified on September 10, 2026. • U.S. stocks weakened after August PPI rose...
🔴 Nasus Pharma is trading 11.34% down today as healthcare and broader markets come under pressure
Nasus Pharma is trading 11.34% down at $3.44, primarily as healthcare and broader markets come under pressure. - The decline reverses the September 8...
🟢 Nasus Pharma is trading 6.37% up today after announcing its H.C. Wainwright conference presentation
Nasus Pharma is trading $3.97 (+6.37%) after announcing management’s presentation at the H.C. Wainwright 28th Annual Global Investment Conference. - The...
🔴 Nasus Pharma is trading 5% down today amid broader healthcare-sector weakness
Nasus Pharma is trading 5.49% down at $3.53, with no clear company-specific negative announcement emerging on September 8, 2026; the decline appears primarily...
🟢 Nasus Pharma is trading 7.33% up in after-hours trading with no confirmed catalyst
Nasus Pharma is trading 7.33% higher at $3.73 in after-hours trading, with no confirmed catalyst. - It closed at $3.53 on September 4, 2026. - No new...
🔴 Nasus Pharma is trading 5.9% down today
Nasus Pharma is trading at $3.53, down -5.88% after opening-session weakness on September 4, 2026. - No new company-specific announcement dated September 4...
🔴 Nasus Pharma is trading 10.1% down today with catalyst unclear
Nasus Pharma is trading 10.1% down at $3.39 after opening-session weakness on September 3, 2026; the catalyst remains unclear. - No new company-specific...
🔴 Nasus Pharma is trading 6.76% down today; no new company-specific announcement identified
Nasus Pharma is trading 6.76% down at $3.52, with no new company-specific announcement dated September 3, 2026 identified. - The stock is weaker after closing...
🟢 Nasus Pharma is trading 5.54% up today amid Healthcare's 1.37% gain
Nasus Pharma is trading 5.54% up at $4.04, with the move appearing primarily sector-driven as Healthcare rises 1.37% alongside a rebound from the prior...
🔴 Nasus Pharma is trading 14.05% down today amid renewed U.S.-Iran tensions
Nasus Pharma is trading 14.05% down at $3.51 after no confirmed company-specific announcement dated September 1, 2026 emerged; the decline appears tied to...
🔴 Nasus Pharma is trading 5.73% down today amid global risk-off pressure
Nasus Pharma is trading 5.73% down now at $3.85 amid global risk-off pressure, including rising rates and geopolitical concerns. - The S&P 500 is down 0.61%,...
🔴 Nasus Pharma is trading 5.6% down today — no confirmed same-day catalyst
Nasus Pharma is trading 5.61% down at $3.87, with no new announcement dated August 31, 2026, or reliable report explicitly explaining the decline. - Latest...
🔴 Nasus Pharma is trading 5.6% down today
Nasus Pharma is trading 5.6% down at $3.87, based on the provided live price; no company announcement dated August 26, 2026, or source-confirmed catalyst...
🔴 Nasus Pharma is trading 5.9% down today as Nasdaq Composite falls amid elevated Treasury yields
Nasus Pharma is trading 5.9% down at $3.77 amid a broadly weaker market. - The Nasdaq Composite is down 0.68%, with risk assets pressured by elevated Treasury...
Nasus Pharma Secures SEC Approval, Clearing Path for Clinical Trial Funding
Nasus Pharma Ltd. received a Notice of Effectiveness from the U.S. Securities and Exchange Commission on August 21, 2026. This regulatory milestone confirms...
🔴 Nasus Pharma Ltd. is trading 5.06% down
NSRX is trading at $3.65, down 5.06%.